Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy

Indian Journal of Ophthalmology

Volumn 56, Issue 3, 2008, Pages 259-

  Shaikh, Saad ^a,b  

^a UNIVERSITY OF CENTRAL FLORIDA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; MONOCLONAL ANTIBODY; VASCULOTROPIN A;

ADULT; CASE REPORT; DRUG ANTAGONISM; FEMALE; HEMOGLOBIN SC DISEASE; HUMAN; LETTER; RETINA NEOVASCULARIZATION; VITREOUS HEMORRHAGE;

ADULT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; FEMALE; HEMOGLOBIN SC DISEASE; HUMANS; RETINAL NEOVASCULARIZATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS HEMORRHAGE;

EID: 42549145446     PISSN: 03014738     EISSN: 19983689     Source Type: Journal    
DOI: 10.4103/0301-4738.40380     Document Type: Letter

References (1)